Cyclic B-type proanthocyanidins in red wines and grapes have been discovered recently. However, proanthocyanidins of a different chemical structure (non-cyclic A-type proanthocyanidins) already known to be present in cranberries and wine possess an identical theoretical mass. As a matter of fact, the retention times and the MS/MS fragmentations found for the proposed novel cyclic B-type tetrameric proanthocyanidin in red wine and the known tetrameric proanthocyanidin in a cranberry extract are herein shown to be identical. Thus, hydrogen/deuterium (H/D) exchange was applied to HPLC-HRMS/MS to confirm the actual chemical structure of the new oligomeric proanthocyanidins. The comparison of the results in water and deuterium oxide and between wine and cranberry extract indicates that the cyclic B-type tetrameric proanthocyanidin is the actual constituent of the recently proposed novel tetrameric species ([CHO], m/z 1153.2608). Surprisingly, the same compound was also identified as the main tetrameric proanthocyanidin in cranberries. Finally, a totally new cyclic B-type hexameric proanthocyanidin ([CHO], m/z 1729.3876) belonging to this novel class was identified for the first time in red wine. Graphical Abstract ᅟ.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13361-017-1876-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction.
Open Heart
January 2025
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Background: The role of cyclic guanosine 3',5'-monophosphate (cGMP) after acute myocardial infarction (AMI) is not well understood despite its significance as a second messenger of natriuretic peptides (NPs) in cardiovascular disease. We investigated the association between the NP-cGMP cascade and left ventricular reverse remodelling (LVRR) in anterior AMI.
Methods: 67 patients with their first anterior AMI (median age, 64 years; male, 76%) underwent prospective evaluation of plasma concentrations of the molecular forms of A-type and B-type natriuretic peptide (BNP) and cGMP from immediately after primary percutaneous coronary intervention (PPCI) to 10 months post-AMI.
Electrochemical Determination of B-Type Natriuretic Peptide with an Epitope-Imprinted Polymer-Based Sensor.
Biosensors (Basel)
November 2024
Department of Materials Science and Engineering, I-Shou University, Kaohsiung 84001, Taiwan.
B-type natriuretic peptides (BNP) are produced and secreted by the myocardium to reduce blood pressure and cardiac load. They cause vasodilation, natriuresis, growth suppression, and inhibition of the sympathetic nervous system and the renin-angiotensin-aldosterone system. The measurement of plasma BNP levels provides clinically useful information concerning the diagnosis and management of left ventricular dysfunction and heart failure, complementing other diagnostic testing procedures.
View Article and Find Full Text PDFRenal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial.
Circ Heart Fail
December 2024
Department of Cardiovascular Medicine (S.A.H., P.M.M.K., H.H.C.), Mayo Clinic, Rochester, MN.
Background: Cardiorenal dysfunction with impaired cyclic GMP (cGMP) response is common in patients presenting with acute heart failure (HF). Type V phosphodiesterase (PDEV) is known to be upregulated in HF and may explain the dysfunction of renal response. The aim of this study was to determine whether B-type natriuretic peptide (BNP) alone or in combination with PDEV inhibition improves renal function and increases urinary sodium and cGMP excretion in acute HF.
View Article and Find Full Text PDFStudy on Pore Water Pressure Model of EICP-Solidified Sand under Cyclic Loading.
Materials (Basel)
September 2024
Shaanxi Key Laboratory of Safety and Durability of Concrete Structures, Xijing University, Xi'an 710123, China.
Article Synopsis
- Saturated sand foundations can experience liquefaction under various loads, making foundation reinforcement crucial for stability and resistance.
- Traditional methods of foundation treatment have drawbacks such as high costs, lengthy construction times, and negative environmental impacts, while enzyme-induced calcium carbonate precipitation (EICP) offers a more sustainable and cost-effective alternative.
- Experimental tests on EICP-treated sand revealed factors like confining pressure and cyclic stress influence pore water pressure and liquefaction resistance, leading to the establishment of a predictive model for pore water pressure behavior, which could help in preventing sand liquefaction.
Sugar/sugar alcohol with glycerol as co-plasticizers for high-content starch/PBAT blown films: from fine structure to physicochemical properties.
J Sci Food Agric
January 2025
College of Food Science and Engineering, Shandong Agricultural University, Tai'an, China.
Background: Glycerol is a well-known plasticizer for starch-based materials, but it easily migrates during starch retrogradation, thereby deteriorating the films' properties. We hypothesized that the performance of high-content starch/poly(butylene adipate-co-terephthalate) (PBAT) films could be enhanced by using sugar/sugar alcohol (glucose, sucrose and sorbitol) as natural, green and edible co-plasticizers with glycerol.
Results: The employment of co-plasticizers reduced the melt fluidity of the blends, established intermolecular hydrogen bonds with starch and resulted in a brittle film structure.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!